183 related articles for article (PubMed ID: 1303308)
21. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
[TBL] [Abstract][Full Text] [Related]
23. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.
Ono M; Nakayama Y; Princler G; Gopas J; Kung HF; Kuwano M
Exp Cell Res; 1992 Dec; 203(2):456-65. PubMed ID: 1459205
[TBL] [Abstract][Full Text] [Related]
24. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR
J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
[TBL] [Abstract][Full Text] [Related]
25. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
26. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
27. Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-ras in short-term primary hepatocyte culture.
Kost DP; Michalopoulos GK
J Cell Physiol; 1990 Jul; 144(1):122-7. PubMed ID: 2195043
[TBL] [Abstract][Full Text] [Related]
28. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains.
Xu L; Shen Y; Joseph T; Bryant A; Luo JQ; Frankel P; Rotunda T; Foster DA
Biochem Biophys Res Commun; 2000 Jun; 273(1):77-83. PubMed ID: 10873567
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid dexamethasone reversibly complements EJ-RAS oncogene to transform mouse embryo BALB-3T3 cells.
Kovary K; Armelin MC; Armelin HA
J Cell Biochem; 1989 Dec; 41(4):171-7. PubMed ID: 2696739
[TBL] [Abstract][Full Text] [Related]
30. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
31. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor.
Stern DF; Roberts AB; Roche NS; Sporn MB; Weinberg RA
Mol Cell Biol; 1986 Mar; 6(3):870-7. PubMed ID: 3022135
[TBL] [Abstract][Full Text] [Related]
32. Differential responsiveness of normal and simian virus 40-transformed BALB/c 3T3 cells to retinoic acid: rapid enhancement of epidermal growth factor receptor binding in a simian virus 40-3T3 variant.
Chen JK; Li LW; Mioh H
Cancer Res; 1987 Oct; 47(19):4995-9. PubMed ID: 3040236
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
[TBL] [Abstract][Full Text] [Related]
34. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation.
Taverna D; Groner B; Hynes NE
Cell Growth Differ; 1991 Mar; 2(3):145-54. PubMed ID: 1676295
[TBL] [Abstract][Full Text] [Related]
36. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor.
Dong XF; Berthois Y; Martin PM
Anticancer Res; 1991; 11(2):737-43. PubMed ID: 2064328
[TBL] [Abstract][Full Text] [Related]
37. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.
MartÃnez-Lacaci I; De Santis M; Kannan S; Bianco C; Kim N; Wallace-Jones B; Wechselberger C; Ebert AD; Salomon DS
J Cell Physiol; 2001 Feb; 186(2):233-42. PubMed ID: 11169460
[TBL] [Abstract][Full Text] [Related]
38. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P
Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532
[TBL] [Abstract][Full Text] [Related]
39. Elevated prostaglandin H synthase gene expression in ras-transformed cells.
Gorman RR; Bienkowski MJ; Lin AH
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():73-6. PubMed ID: 1825590
[TBL] [Abstract][Full Text] [Related]
40. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
